Learn more

GENODYSSEE

Overview
  • Total Patents
    64
About

GENODYSSEE has a total of 64 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PGXHEALTH LLC, ROSTAQUO S P A and INCYTE GENOMICS INC.

Patent filings per year

Chart showing GENODYSSEEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Escary Jean-Louis 47
#2 Escary Jean Louis 9
#3 Escary J-L 2
#4 Jean-Louis Escary 1

Latest patents

Publication Filing date Title
EP1972687A1 Polynucleotides and polypeptides of human factor VII gene, SNPs
EP1418428A1 Method to provide natural therapeutic agents with high therapeutic index
AU2002327824A1 Identification of snps the hgv-v gene
IL158261D0 New polynucleotides and polypeptides of the erythropoietin gene
EP1312614A1 Polynucleotides and polypeptides of the GCP-2 gene
EP1308458A1 New polynucleotides and polypeptides of the CX26 gene
EP1295938A1 Corrected sequence of the hGH-V gene and an allelic variant
FR2825716A1 Novel polynucleotides and polypeptides from ifn alpha 7
FR2825102A1 Novel polynucleotides and polypeptides of interferon alpha 14
FR2824333A1 Novel polynucleotides and polypeptides of ifn alpha 5
FR2823764A1 Novel polynucleotides and polypeptides of the ifn alpha-17 gene
FR2823763A1 New polynucleotides and polypeptides of interferon alpha-6 gene comprising at least one single nucleotide polymorphism, useful for preventing or treating e.g. cancer, asthma, allergies, psoriasis, AIDS or Parkinson's disease
FR2823220A1 Novel erythropoietin (epo) polynucleotides and polypeptides
FR2822845A1 Novel polynucleotides comprising functional snp-like polymorphisms in the nucleotide sequence of the ifn-alpha-21 gene as well as new polypeptides encoded by these polynucleotides and their therapeutic uses
FR2821625A1 Novel polynucleotides comprising functional snp-type polymorphism in the nucleotide sequence of the ifn-alpha-2 gene as well as new polypeptides encoded by these polynucleotides and their therapeutic uses
FR2817559A1 Method for determining one or more functional polymorphism (s) in the nucleic sequence of a preselected functional "candidate" gene and its applications